Ranbaxy
Delhi HC attaches Ranbaxy promoters’ assets to enforce Daiichi award
26 Feb 2018
The court issued warrants of attachment on the assets of Malvinder Singh and Shivinder Singh, including shares, moveable and immovable property, art as well as debts owed to Oscar Investments and RHC Holding besides asking the Singh brothers to disclose all their assets
Daiichi case: thwarted in SC, Singhs may return to Singapore courts
17 Feb 2018
Brothers Malvinder and Shivinder Singh are “evaluating the option to challenge the ... award in Singapore courts” after the Supreme Court upheld a high court verdict that they must pay Daiichi Sankyo $546 million
Ranbaxy’s Singh bros must pay Daiichi Rs3,500 cr, rules HC
01 Feb 2018
In a petition filed at the Delhi HC, Daiichi had sought to enforce collection of Rs3,500-crore arbitration award it won at a Singapore tribunal in 2016 against Ranbaxy
Ranbaxy ex-bosses to challenge Rs2,562-cr fine for hiding info from Daiichi
06 May 2016
In a majority ruling this week, a three-member arbitration panel in Singapore imposed a fine on the billionaire brothers earlier this week in a case filed by Daiichi Sankyo in 2013
Former Ranbaxy promoters ordered to pay Rs2,500 cr damages
06 May 2016
Daiichi filed an arbitration case in 2013 in Singapore, accusing the Indian promoters of concealment and misrepresentation of facts and seeking compensation for fines that it was forced to pay the US Department of Justice
Sun, Ranbaxy complete $4-bn merger
24 Mar 2015
On Tuesday, the Reserve Bank of India approved the issue of equity shares of Sun Pharma to non-resident holders of equity shares of Ranbaxy, facilitating the merger through a scheme of arrangement
.webp)
